Intrahepatic Cholangiocarcinoma  >>  melphalan  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
melphalan / Generic mfg.
NCT00096083: Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Completed
2
56
US
isolated perfusion, melphalan
Delcath Systems Inc., National Cancer Institute (NCI)
Cancer
08/12
08/12

Download Options